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Abstract
Background: Higher coffee consumption has been associated with a lower risk of type 2 diabetes in cohort
studies, but the physiological pathways through which coffee affects glucose metabolism are not fully understood.
The aim of this study was to evaluate the associations between habitual coffee and tea consumption and glucose
metabolism in a multi-ethnic Asian population and possible mediation by inflammation.
Methods: We cross-sectionally examined the association between coffee, green tea, black tea and Oolong tea
consumption and glycemic (fasting plasma glucose, HOMA-IR, HOMA-beta, plasma HbA1c) and inflammatory
(plasma adiponectin and C-reactive protein) markers in a multi-ethnic Asian population (N = 4139).
Results: After adjusting for multiple confounders, we observed inverse associations between coffee and HOMA-IR
(percent difference: - 8.8% for ≥ 3 cups/day versus rarely or never; Ptrend = 0.007), but no significant associations
between coffee and inflammatory markers. Tea consumption was not associated with glycemic markers, but green
tea was inversely associated with plasma C-reactive protein concentrations (percent difference: - 12.2% for ≥ 1 cup/
day versus < 1 cup/week; Ptrend = 0.042).
Conclusions: These data provide additional evidence for a beneficial effect of habitual caffeinated coffee
consumption on insulin sensitivity, and suggest that this effect is unlikely to be mediated by anti-inflammatory
mechanisms.
Background
T h ep r e v a l e n c eo fT y p e - 2d i a b e t e sm e l l i t u s( T y p e - 2
DM) is rising rapidly in Asian countries [1,2], and iden-
tifying lifestyle measures to improve insulin sensitivity
and prevent Type-2 DM in these populations is particu-
larly important. Data from multiple prospective cohort
studies [3], including results from Asian populations
[4,5], indicate that coffee consumption is associated with
a lower risk of Type-2 DM. Results from several cross-
sectional studies suggest that an association between
coffee consumption and insulin sensitivity may contri-
bute to this association [6,7]. Because coffee is a rich
source of anti-oxidants [8], and sub-clinical inflamma-
tion has been implicated in the development of insulin
resistance (IR) [9] coffee may improve insulin sensitivity
by decreasing inflammation. Inflammatory markers
including higher C-reactive protein (CRP) and lower
adiponectin concentrations have been associated with
insulin resistance [10,11].
However, studies on coffee consumption and inflam-
matory outcomes have yielded inconsistent results. Cof-
fee consumption was associated with lower plasma CRP
concentrations in four cross-sectional studies [12-15],
with higher CRP concentrations in a Greek population
[16], and with no change in CRP concentrations in a
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coffee consumption in relation to adiponectin concen-
trations. In cross-sectional studies in the U.S. [18] and
Japan [19] coffee consumption was associated with
higher adiponectin concentrations, whereas another
study in Japan [20] observed no such association. In an
intervention study, serum adiponectin concentration
increased when participants consumed eight cups of cof-
fee per day as compared to when they did not consume
coffee [17]. These studies did not distinguish between
high-molecular weight and lower molecular weight adi-
ponectin that may have different metabolic effects [21].
There is less consistent evidence on the association
between tea consumption and risk of Type-2 DM [3].
Data on the effects of tea in relation to glycemic para-
meters and inflammatory markers are inconclusive [22]
and are mostly limited to green tea [23-26]. Since the
putative bioactive compounds in tea vary by type, some
of the discrepancies may be related to the type of tea
consumed.
The main aim of this study was to evaluate consump-
tion of coffee and three type of tea (black, green and
Oolong) in relation to markers of inflammation, insulin
sensitivity, and glycemia in a multi-ethnic population
consisting of Chinese, Malays and Asian-Indians. We
hypothesized that coffee and tea consumption are asso-
ciated with lower IR and that this association can
be partly explained by plasma adiponectin and CRP
concentrations.
Methods
Study Population
In this study we used cross-sectional data from the Sin-
gapore Prospective study-2 (SP2) cohort. This study
conducted between 2003-2007, was a follow-up of per-
sons participating in four previous Singaporean popula-
tion-based studies: the Thyroid and Heart Study [27],
the National Health Survey-1992 [28], National Univer-
sity of Singapore Heart Study [29] and the National
Health Survey-1998 [30] which were conducted between
1982 and 1998. These studies used a stratified random
sampling method, disproportionate for ethnicity to
increase representation of the minority Malay and
Asian-Indian ethnic groups. The total participant pool
derived from these studies consisted of 10,747 persons,
of which 667 were not available (deceased, emigrated,
errors in identity number recording) [31]. For the SP2
study, an interviewer-administered questionnaire was
completed during a home visit by 7744 participants, and
5163 of these participants attended a clinic visit. Data
on demographic and lifestyle characteristics and medical
history were collected during the interview and fasting
blood samples were obtained during the clinic visit for
measuring biochemical markers [32]. For the present
analyses, we only included people who attended the
clinic visit (n = 5163). We excluded data from partici-
pants who reported pre-existing diabetes (n = 494), car-
diovascular disease (n = 213) and current cancer (n =
56) or those for whom these data were missing (n = 76).
We also excluded people who reported their race as
‘other’ (n = 3) and those who were pregnant (n = 2). Of
the remaining 4417 people, 220 had an implausible
energy intake (> 7000 or < 400 kcal/day, or who had an
energy intake to energy expenditure ratio that fell in
extreme 2.5 percentile range) and 35 people had
reported changing their beverage intake in the month
preceding the questionnaire. After excluding these peo-
ple, 22 had missing covariate data. After these exclu-
sions our final dataset comprised of 4139 participants.
The study was approved by the Singapore General Hos-
pital and the National University Hospital Institutional
Review Boards.
Dietary data
Dietary intake data during the month preceding the
interview was assessed using a semi-quantitative 169-
item validated food frequency questionnaire that is used
in the National Nutrition Surveys [33]. Participants were
asked to estimate their frequency of consuming each
food group, based on a standard portion size specific for
that food group. Participants could report consumption
per day, per week or per month, or could report to
never or rarely consume a food. Nutrient intakes were
computed by the Health Promotion Board of Singapore,
using their in-house database.
Data on coffee intake were obtained by asking partici-
pants about the habitual amount of coffee consumed.
Participants could select one of seven responses ranging
from ‘never/rarely’ to ‘10 or more cups per day’,w i t h1
cup being defined as a “standard coffee-shop cup” of
215 ml. Similar questions were asked about green,
Oolong and black tea. Coffee intake was grouped into
four categories (never/rarely, < 1 cup/day, 1-2 cups/day
and ≥ 3 cups per day) and tea intake into 3 categories
(< 1 cup/week, 2-6 cups/wk, ≥ 1 cup per day) for data
analyses to avoid categories with small numbers. The
questionnaire also elicited information on the amount of
sugar and the type and amount of milk/cream added to
coffee and tea. Although data on type of coffee were not
collected, decaffeinated coffee intake is very low in the
Singapore population [4].
Assessment of covariates
Height was measured using a wall mounted measuring
tape and weight was measured using a digital scale. BMI
w a sc o m p u t e da sw e i g h t( k g )d i v i d e db yh e i g h t( m
2).
Physical activity level and smoking status was assessed
from the questionnaire and alcohol intake was obtained
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a validated questionnaire on household, occupational,
leisure-time and transport activity [34]. Participants who
used medications to lower cholesterol or triglycerides or
increase HDL-C concentrations, or who reported having
been diagnosed with hypercholesterolemia were consid-
ered to have a history of dyslipidemia. Participants who
used anti-hypertensive medication or reported having
been diagnosed by a physician with hypertension were
considered to have a history of hypertension.
Laboratory Analyses
Fasting plasma samples were analyzed for glucose using
enzymatic methods (ADVIA 2400, Siemens, Germany).
Fasting blood samples were used to measure HbA1c
using high pressure liquid chromatography on a Biorad
V a r i a n tI Ia n a l y z e r( B i o - r a dl aboratories, Hercules, CA,
USA). Fasting serum samples were analyzed for insulin,
u s i n gm i c r o - p a r t i c l ee n z y m ei m m u n o a s s a y( A b b o t t
AXSYM, Abbott Laboratories, Chicago, IL), for high-
sensitivity C-reactive protein, using an immunoturbidi-
metric assay (Roche Diagnostics, Rotkreuz, Switzerland),
and for total and high molecular weight (HMW) adipo-
nectin using an enzyme linked immunosorbent assay
(Sekisui Medical Co Ltd, Japan). The intra and inter
batch coefficent of variations percent were as follows;
glucose (2.5, 6.6), insulin (4.0, 4.5), HbA1c (0.0-2.0,
0.85-1.54), total adiponectin (18.1, 15.9) HMW adipo-
nectin (6.8, 18.3) and CRP (intraassay precision, 0.6%-
1.3%; interassay precision, 2.3%-3.1%).
Statistical Analyses
All response variables were transformed using natural
logarithms to approximate normality. The means and
95% confidence intervals (CIs) were then exponentiated
to obtain geometric means and 95% CIs. Values for
response variables that were more than four standard
deviations from the mean were considered outliers and
were excluded from the analyses. The HOMA-IR index
was computed as fasting plasma glucose mmol/L × fast-
ing serum insulin (mU/L)/22.5 and the HOMA-beta
index was computed as 20 × fasting serum insulin (mU/
L)/fasting plasma glucose (mmol/L -3.5) [35]. Participant
characteristics were compared across categories of coffee
and tea using Kruskal-Wallis (for non-normally distribu-
ted continuous variables), analysis of variance (for nor-
mally distributed continuous variables) or the chi-
squared test (for categorical variables). Multiple linear
regression analyses were performed using HOMA-IR,
HOMA-beta, plasma glucose, HbA1c, plasma insulin,
CRP, total adiponectin and HMW adiponectin as depen-
dant variables and coffee or tea as independent
variables. Linear estimators were fitted using two multi-
variate models: Model 1:adjusted for age, sex and
ethnicity Model 2: further adjusted for BMI (kg/m
2),
physical activity (kcal/week), education level, alcohol
consumption, cigarette smoking, history of dyslipidemia,
history of hypertension and dietary factors i.e. energy
intake (kcal), fiber (per 1000 kcal), cholesterol (per 1000
kcal), PUFA (% energy), MUFA (% energy), SFA (%
energy), coffee (for tea analyses) and tea (for coffee ana-
lyses). HOMA-beta, as a marker for beta cell function
must be considered within the context of IR, because
insulin sensitivity regulates insulin secretion [36]. Mod-
els for HOMA-beta were therefore further adjusted for
HOMA-IR. Residual plots and Cooks distance test
(Cooks D < 1.0) was used to assess if there were influen-
tial points in the multivariate models [37]. Influential
points were not observed with a maximum Cooks Di of
0.03. For trend tests, the median number of cups of cof-
fee or tea consumed in each coffee category or each tea
category was treated as a continuous variable. We tested
for interactions with overweight status by including
multiplicative interaction terms in the model after
adjusting for all potential confounders. To evaluate
whether additions to coffee modified observed associa-
tions, stratified analyses were performed for groups of
participants that reportedly added or did not add milk
to coffee, and for those that reportedly added or did not
add sugar to beverages excluding individuals who used
the other type of coffee. Because strong correlations
were noted between HOMA-IR and fasting insulin
(rspearman = 0.98) and between total and HMW adipo-
nectin (rspearman = 0.94), results are not presented for
fasting insulin and total adiponectin. All data were ana-
lyzed using SPSS v11 (SPSS Inc. Chicago, IL). P-values <
0.05 were considered statistically significant
Results
Participant Characteristics
Coffee drinkers were more likely to be older, male,
non-tea drinkers, alcohol consumers, cigarette smokers
with higher physical activity, a lower education level,
and less healthy dietary choices (Table 1).M o s tc o f f e e
drinkers consumed their coffee with milk/cream
(71.4%) and sugar (63.0%) Characteristics of tea drin-
kers varied by type of tea consumed (Additional file
1Table S1). Black tea and Oolong tea drinkers were
m o r el i k e l yt ob eo l d e r ,m a l ea n dh a v eh i g h e rB M I .
Green tea consumers were more likely to be younger.
C h i n e s ew e r em o r el i k e l yt o consume Oolong or green
tea, and less likely to consume black tea than Indians
or Malay. Black tea consumption was associated with
less health conscious dietary intakes, and more physical
activity. Oolong and green tea drinkers were more
likely to consume alcohol. Regardless of tea type, tea
drinkers were more likely to be highly educated and to
have known hypertension.
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inflammatory markers
No associations between coffee and glycemic markers
were noted in age, sex and ethnicity adjusted models
(Table 2). However, after adjusting for BMI, coffee con-
sumption was inversely associated with IR (Ptrend=
0.021), an association that remained after further adjust-
ment for dietary covariates and history of hypertension
and dyslipidemia (percent difference: - 8.8% for ≥ 3 cups
per day versus rarely or never; Ptrend = 0.007). This asso-
ciation did not differ significantly by ethnicity (Pinteraction
= 0.769) or overweight status (BMI < or ≥ 25 kg/m
2)
(Pinteraction = 0.374). Coffee consumption was not asso-
ciated with plasma CRP and adiponectin in any of the
models (Table 2). Consistent with this observation, the
association between coffee consumption and HOMA-IR
was not substantially weaker after further adjustment for
inflammatory markers (percent difference = -7.7% for ≥
3 cups/day versus rarely or never; Ptrend = 0.021) (Table
2). The association between coffee and IR was similar
for coffee with added milk (percent difference = - 8.76%
for ≥ 3 cups/day versus rarely or never; Ptrend = 0.0078)
and coffee without added milk (percent difference = -
8.56%; Ptrend = 0.1943; Pinteraction = 0.9165) and for
added sugar (percent difference = - 7.23%; Ptrend =
0.0452) and no added sugar (percent difference = -
12.21%; Ptrend = 0.007; Pinteraction = 0.6041).
Associations between tea and glycemic and inflammatory
markers
Black, Oolong, and green tea consumption were not sig-
nificantly associated with glycemic markers in fully
Table 1 Characteristics of study participants across categories of coffee consumed
a
Total Never or
rarely
(n = 1202)
< 1 cup per day
(n = 475)
1-2 cups per
day
(n = 2118)
≥ 3 cups per day
(n = 344)
P-
value
Age (y) 48.8 ± 11.3 46.9 ± 11.7 47.1 ± 11.7 50.2 ± 11.0 49.2 ± 9.9 <0.001
BMI (kg/m
2) 23.2 (20.8 - 26.0) 23 (20.4 -
26.09)
23.2 (20.5 - 25.9) 23.3 (20.9 - 26.1) 23.4(21.5 - 26.0) 0.0317
Females, n (%) 2218 (53.6) 739 (61.5) 265 (55.8) 1112 (52.5) 102 (29.7) <0.001
Ethnicity, n (%) 0.117
Chinese 2868 (69.3) 793 (66.0) 337 (70.9) 1503 (71.0) 235 (68.3)
Malay 698 (16.9) 228 (19.0) 77 (16.2) 332 (15.7) 61 (17.7)
Indian 573 (13.8) 181 (15.1) 61 (12.8) 283 (13.4) 48 (14.0)
Primary education and below, n
(%)
998 (24.1) 236 (19.6) 99 (20.8) 569 (26.9) 94 (27.3) < 0.001
Alcohol consumption, n (%) 0.003
Non-drinker 3371 (81.4) 1016
(84.5)
379 (79.8) 1711 (80.8) 265 (77.0)
< 1 serving per day 690 (16.7) 175 (14.6) 88 (18.5) 356 (16.8) 71 (20.6)
≥ 1 serving per day 78 (1.9) 11 (0.9) 8 (1.7) 51 (2.4) 8 (2.3)
Current cigarette smoking, n (%) 485 (11.7) 76 (6.3) 41 (8.6) 262 (12.4) 106 (30.8) < 0.001
Black tea (cups/week)
b 4.4 ± 6.0 5.5 ± 7.0 4.6 ± 5.5 3.7 ± 5.2 4.0 ± 6.9 < 0.001
Chinese tea (cups/week)
b 2.1 ± 5.2 2.1 ± 5.5 2.8 ± 6.1 2.0 ± 4.7 1.8 ± 5.6 < 0.001
Green tea (cups/week)
b 1.6 ± 3.9 1.7 ± 4.0 2.0 ± 4.2 1.4 ± 3.8 1.4 ± 3.9 < 0.001
Physical activity (kcal/week) 3694 (1922 -
6728)
3736 (1810 -
7086)
3353 (1885 - 5999) 3725 (1952 - 6605) 4160(2075 - 8055) 0.031
% energy from SFA 11.1 ± 2.8 11 ± 2.9 10.9 ± 2.7 11 ± 2.8 11.8 ± 2.8 < 0.001
% energy from MUFA 9.7 ± 2.6 9.8 ± 2.7 9.8 ± 2.6 9.6 ± 2.6 9.5 ± 2.6 0.115
% energy from PUFA 5.3 (4.2 - 7.3) 5.6 (4.2 - 7.6) 5.4 (4.2 - 7.2) 5.3 (4.2 - 7.2) 4.7 (3.8 - 6.4) < 0.001
Fiber (g per 1000 kcal) 10.5 (9.1 - 12.3) 11.0 (9.3 -
12.8)
10.6 (9.3 - 12.4) 10.5 (9.1 - 12.2) 9.2 (8.0 - 10.8) < 0.001
Cholesterol (mg per 1000 kcal) 113.6 (88.0 -140.5) 112.2 (86.4 -
141.9)
110.5 (86.3 -
141.3)
114.3 (88.7 - 138.2) 116.9 (93.0 -
146.6)
0.016
History of hypertension, n (%) 710 (17.2) 214 (17.8) 80 (16.8) 373 (17.6) 43 (12.5) 0.114
History of dyslipidemia, n (%) 1139 (27.5) 311 (25.9) 117 (24.6) 609 (28.8) 102 (29.7) 0.111
a Abbreviations: SFA; saturated fatty acid, MUFA; monounsaturated fatty acids, PUFA; polyunsaturated fatty acids. Data are presented as mean ± SD, median (IQR)
or n (%) unless otherwise specified.
b Median values were assigned to each category of coffee/tea as follows: never/rarely; 0, < 1 cup/week; 0.4, > than 1 cup/wk but < 1cup/d; 4;1-2 cups/d; 10.5; 3-5
cups/d; 28; 6-9 cups/day; 52.5 and 10 or more cups/day; 70. Means and SD are presented in the tables; due to skewed data the Kruskal-Wallis test was used to
test for differences between categories.
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was not significantly associated with inflammatory mar-
kers in age, sex and ethnicity adjusted models. However
after adjustment for other potential confounders, green
tea consumption was significantly associated with lower
CRP concentrations (percent difference: - 12.2% for ≥ 1
cup/day versus < 1 cup/week; Ptrend =0 . 0 4 2 )( T a b l e5 ) .
This association was not modified by BMI status (Pinter-
action = 0.1032) or ethnicity (Pinteraction = 0.939). Few
people consumed three or more cups of a given tea-type
(N = 32, 71 and 98 for green, Oolong and black tea
respectively), making it less meaningful to look at higher
categories of tea intake. When we summed tea intake
across the different types of tea, we found no significant
associations between tea consumption and metabolic
markers (Additional file 1Table S2).
Discussion
In this study, in a multi-ethnic Singaporean population,
coffee consumption was inversely associated with IR inde-
pendent of plasma CRP or adiponectin concentrations.
This association appeared to be consistent for overweight
and non-overweight participants and for Chinese, Malay,
and Asian Indian participants. We also noted an inverse
relationship between green tea and plasma CRP concen-
trations, but found no evidence for an association between
tea consumption and basal glucose metabolism.
To the best of our knowledge this is the first study to
examine the extent to which inflammatory markers such
as CRP and adiponectin explain the association between
coffee consumption and IR. Data from other clinical and
cross-sectional studies suggest a beneficial effect of cof-
fee consumption on insulin sensitivity. However few
studies have examined coffee in relation to insulin sensi-
tivity [6] or inflammation [13,15,19,20] in Asian popula-
tions and these studies were all conducted in Japan.
These cross-sectional studies found inverse associations
between coffee and serum CRP concentrations [13,15],
and either no association [20] or a direct association
[19] with serum adiponectin concentrations. Both adipo-
nectin and CRP have been associated with Type-2
DM risk [38,39]. Adiponectin can also decrease IR,
Table 2 Geometric means (95% CI) of glycemic and inflammatory parameters by categories of coffee consumption
a
Never or rarely < 1 cup/day 1-2 cup(s)/day ≥ 3 cups/day P trend
b
Fasting plasma glucose (mmol/L)
Model-1
c 4.83 (4.79 - 4.86) 4.81 (4.75 - 4.86) 4.86 (4.83 - 4.89) 4.82 (4.76 - 4.88) 0.554
Model-2 4.76 (4.69 - 4.82) 4.73 (4.66 - 4.81) 4.78 (4.72 - 4.84) 4.74 (4.66 - 4.82) 0.916
HOMA-IR
Model-1 1.58 (1.52 - 1.65) 1.54 (1.44 - 1.64) 1.56 (1.51 - 1.62) 1.53 (1.42 - 1.64) 0.449
Model-2 1.47 (1.38 - 1.57) 1.41 (1.30 - 1.52) 1.41 (1.32 - 1.50) 1.34 (1.23 - 1.46) 0.007
Model-3
d 1.43 (1.34 - 1.53) 1.36 (1.26 - 1.47) 1.36 (1.28 - 1.45) 1.32 (1.22 - 1.44) 0.021
HOMA-beta
Model-1 104.68 (101.2 - 108.28) 105.57 (100.27 - 111.15) 100.54 (97.81 - 103.35) 106.42 (100.24 - 112.98) 0.715
Model-2 106.24 (99.34 - 113.63) 106.15 (98.43 - 114.47) 101.9 (95.64 - 108.57) 107.02 (98.29 - 116.51) 0.591
HbA1c %
Model-1 5.79 (5.76 - 5.83) 5.72 (5.67 - 5.78) 5.78 (5.76 - 5.81) 5.8 (5.74 - 5.86) 0.567
Model-2 5.75 (5.69 - 5.82) 5.69 (5.62 - 5.76) 5.72 (5.66 - 5.78) 5.72 (5.64 - 5.8) 0.375
Adiponectin (high molecular weight) µg/ml
Model-1 1.03 (0.98 - 1.08) 1.04 (0.97 - 1.12) 1.02 (0.98 - 1.06) 1.03 (0.95 - 1.12) 0.953
Model-2 0.99 (0.91 - 1.08) 1.02 (0.92 - 1.12) 1.00 (0.92 - 1.08) 1.04 (0.93 - 1.16) 0.347
CRP (mg/L)
Model-1 1.42 (1.32 - 1.52) 1.59 (1.43 - 1.77) 1.49 (1.41 - 1.58) 1.59 (1.41 - 1.81) 0.139
Model-2 1.31 (1.16 - 1.49) 1.43 (1.25 - 1.65) 1.28 (1.14 - 1.44) 1.23 (1.05 - 1.44) 0.185
a HOMA-IR, homeostatic model assessment-insulin resistance; HOMA-beta, homeostatic model assessment-beta cell function; CRP, C-reactive protein. Numbers of
participants differ across outcomes because participants with outlier values (response values > 4 SD from mean) were excluded. These numbers across the 4
categories of coffee consumption are fasting plasma glucose: 1187,461,2084,342; HOMA-IR: 1195,468,2102,343; HOMA-beta: 1187, 468, 2097, 343; HbA1c: 967,
388, 1717, 281; HMW adiponectin: 1176, 452, 2056, 333 and CRP: 1168, 450, 2046, 331.
b P-values were obtained from multiple linear regression models with median cups of coffee per week (0, 4,10.5 and 28) as predictors and log transformed
parameters as dependant variables.
c Model-1: adjusted for age (years), sex and ethnicity (Chinese, Malay, Indian).
Model-2: adjusted for Model-1 covariates (above) and BMI (kg/m
2), physical activity level (kcal/week), education level (primary, secondary, polytechnic/diploma
and university), alcohol level (non-drinkers, < 1 serving/day, and ≥ 1 serving/day), cigarette smoking (never-smokers, ex-smokers, current smokers < 10 cigarettes/
d, and current smokers ≥ 10 cigarettes/d), history of dyslipidemia (yes/no), history of hypertension (yes/no), and dietary confounders i.e. energy intake (kcal), fiber
(per 1000 kcal), cholesterol (per 1000 kcal), PUFA (% energy), MUFA (% energy), SFA (% energy), green, black, Oolong tea (never/< 1cup per week, 2-6 cups per
week, ≥ 1 cup(s) per day). HOMA-beta models were further adjusted for HOMA-IR.
d Model-3 was further adjusted for CRP and adiponectin
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AMP-activated protein kinase pathway [40].
Although we observed an inverse association between
coffee consumption and IR, we found no significant
associations between coffee intake and inflammatory
markers and these markers did not explain the associa-
tion between coffee and IR. These results suggest that
t h ep u t a t i v ep r o t e c t i v ee f f ect of coffee consumption
against the development of Type-2 DM, which has been
previously reported in Singapore Chinese [4], is at least
partly mediated by its effects on IR. However, this
inverse association between coffee consumption and IR
is probably not mediated by anti-inflammatory effects.
Nevertheless, there are some caveats that are worth con-
sidering. First, although CRP is a well-established mar-
ker of systemic inflammation [41], it is possible that
coffee alters other measures of inflammation that were
not examined in this study. Second, the relatively low
amounts of coffee consumed in this population, may
have been insufficient to exert a biological effect on
CRP and adiponectin. In a cross-sectional study of U.S.
women, only consuming four or more cups of coffee per
day, but not lower consumption, was associated with
higher adiponectin concentrations [18]. However, the lit-
erature on this topic is not consistent with a few other
studies suggesting associations with concentrations of
CRP and adiponectin at intakes as low as one cup per
day [13,19].
Apart from its anti-inflammatory effects, phenolic
compounds in coffee have been postulated to affect glu-
cose metabolism through various mechanisms including
intestinal glucose absorption and incretin secretion [8],
and reduction of hepatic triglyceride accumulation [8].
Consistent with several intervention studies, no associa-
tions were noted between black or green tea, and fasting
glycemic parameters in this investigation [23,24,26]. In
contrast, a Japanese intervention study, noted reduced
fasting plasma glucose and fructosamine concentrations
in diabetic participants who consumed 1 L per day of
Oolong tea for four weeks [42]. The difference in dia-
betes status or amount of tea consumed may have con-
tributed to the difference in results as compared with
our study.
Tea consumption was not associated with adiponectin
concentrations in our study. This is consistent with stu-
dies that showed no associations between green tea and
Table 3 Geometric means (95% CI) of glycemic and inflammatory parameters by categories of black tea consumption
a
never or < 1 cup per week 2-6 cups per week ≥ 1 cup(s) per day P trend
b
Fasting plasma glucose (mmol/L)
Model-1
c 4.86 (4.83 - 4.89) 4.81 (4.77 - 4.86) 4.83 (4.80 - 4.86) 0.144
Model-2 4.78 (4.72 - 4.84) 4.73 (4.66 - 4.80) 4.75 (4.68 - 4.81) 0.115
HOMA-IR
Model-1 1.55 (1.50 - 1.60) 1.49 (1.42 - 1.57) 1.61 (1.55 - 1.67) 0.141
Model-2 1.43 (1.34 - 1.52) 1.35 (1.25 - 1.45) 1.44 (1.35 - 1.54) 0.579
HOMA-beta
Model-1 101.07 (98.18 - 104.04) 105.48 (101.04 - 110.13) 103.83 (100.59 - 107.17) 0.169
Model-2 103.34 (96.79 - 110.34) 107.12 (99.69 - 115.10) 105.49 (98.70 - 112.76) 0.320
HbA1c %
Model-1 5.79 (5.76 - 5.82) 5.75 (5.71 - 5.80) 5.79 (5.76 - 5.82) 0.987
Model-2 5.73 (5.67 - 5.80) 5.71 (5.64 - 5.78) 5.72 (5.66 - 5.79) 0.698
Adiponectin: high-molecular weight (µg/ml)
Model-1 1.05 (1.01 - 1.09) 1.02 (0.96 - 1.08) 1 (0.96 - 1.05) 0.110
Model-2 1.03 (0.94 - 1.12) 1.01 (0.92 - 1.11) 1 (0.92 - 1.09) 0.327
CRP (mg/L)
Model-1 1.50 (1.41 - 1.59) 1.46 (1.33 - 1.60) 1.49 (1.40 - 1.59) 0.929
Model-2 1.34 (1.19 - 1.52) 1.28 (1.12 - 1.46) 1.32 (1.17 - 1.5) 0.730
a HOMA-IR, homeostatic model assessment-insulin resistance; HOMA-beta, homeostatic model assessment-beta cell function; CRP, C-reactive protein. Numbers of
participants differ across outcomes because participants with outlier values (response values > 4 SD from mean) were excluded. Numbers were as follows: fasting
plasma glucose: 2130, 723, 1221 HOMA-IR: 2148, 727, 1233, HOMA-beta: 2143, 725, 1227, HbA1c: 1758, 587, 1008 HMW adiponectin: 2097, 705, 1215; and CRP:
2082, 700, 1213.
b P-values were obtained from multiple linear regression models with median cups of tea per week (0, 4,10.5) as predictors and log transformed parametersa s
dependant variables.
c Model-1: adjusted for age (years), sex and ethnicity (Chinese, Malay, Indian).
Model-2: adjusted for Model 1 covariates (above) and BMI (kg/m
2), physical activity level (kcal/week), education level (primary, secondary, polytechnic/diploma
and university), alcohol level (non-drinkers, < 1 serving/day, and ≥ 1 serving/day), cigarette smoking (never-smokers, ex-smokers, current smokers < 10 cigarettes/
d, and current smokers ≥ 10 cigarettes/d), history of dyslipidemia (yes/no), history of hypertension (yes/no), and dietary confounders i.e. energy intake (kcal), fiber
(per 1000 kcal), cholesterol (per 1000 kcal), PUFA (% energy), MUFA (% energy), SFA (% energy), coffee (never/rarely, < 1 cup per day, 1-2 cup(s) per day, ≥ 3
cups/day) and alternate teas (never or < 1 cup per week, 2-6 cups per week, ≥ 1 cup(s) per day). HOMA-beta models were further adjusted for HOMA-IR.
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Page 6 of 10Table 4 Geometric means (95% CI) of glycemic and inflammatory parameters by categories of Oolong tea
consumption
a
never or < 1 cup per week 2-6 cups per week ≥ 1 cup(s) per day P trend
b
Fasting plasma glucose (mmol/L)
Model-1
c 4.84 (4.82 - 4.86) 4.82 (4.77 - 4.87) 4.86 (4.81 - 4.92) 0.591
Model-2 4.75 (4.69 - 4.82) 4.75 (4.68 - 4.82) 4.76 (4.68 - 4.83) 1.000
HOMA-IR
Model-1 1.56 (1.51 - 1.60) 1.56 (1.47 - 1.65) 1.68 (1.57 - 1.79) 0.044
Model-2 1.41 (1.32 - 1.50) 1.40 (1.30 - 1.51) 1.41 (1.30 - 1.53) 0.940
HOMA-beta
Model-1 102.50 (100.2 - 104.85) 105.31 (100.28 - 110.60) 103.70 (98.02 - 109.71) 0.511
Model-2 103.83 (97.48 - 110.60) 106.22 (98.69 - 114.32) 105.89 (97.91 - 114.52) 0.428
HbA1c %
Model-1 5.78 (5.76 - 5.81) 5.76 (5.71 - 5.80) 5.81 (5.76 - 5.87) 0.461
Model-2 5.72 (5.66 - 5.78) 5.71 (5.64 - 5.78) 5.73 (5.66 - 5.81) 0.685
Adiponectin- high molecular weight (µg/ml)
Model-1 1.03 (1.00 - 1.06) 1.04 (0.97 - 1.11) 0.96 (0.89 - 1.03) 0.105
Model-2 1.01 (0.93 - 1.09) 1.04 (0.94 - 1.14) 0.99 (0.89 - 1.09) 0.829
CRP (mg/L)
Model-1 1.48 (1.41 - 1.55) 1.46 (1.32 - 1.62) 1.63 (1.45 - 1.83) 0.166
Model-2 1.29 (1.14 - 1.45) 1.30 (1.13 - 1.49) 1.35 (1.17 - 1.56) 0.397
a HOMA-IR, homeostatic model assessment-insulin resistance; HOMA-beta, homeostatic model assessment-beta cell function; CRP, C-reactive protein. Numbers of
participants differ across outcomes because participants with outlier values (response values > 4 SD from mean) were excluded. Numbers were as follows: fasting
plasma glucose: 3058, 585, 431 HOMA-IR: 3087, 588, 433 HOMA-beta: 3080, 588, 427 HbA1c: 2493, 482, 378 HMW adiponectin: 3020, 572, 425 CRP: 3012, 564,
419.
b, c For these footnotes please refer to Table 3
Table 5 Geometric means (95% CI) of glycemic and inflammatory parameters by categories of green tea consumption
a
never or < 1 cup per week 2-6 cups per week ≥ 1 cup(s) per day P trend
b
Fasting plasma glucose (mmol/L)
Model-1
c 4.84 (4.82 - 4.86) 4.83 (4.78 - 4.88) 4.87 (4.80 - 4.93) 0.575
Model-2 4.75 (4.69 - 4.81) 4.75 (4.68 - 4.82) 4.76 (4.68 - 4.85) 0.687
HOMA-IR
Model-1 1.55 (1.51 - 1.60) 1.60 (1.51 - 1.69) 1.65 (1.53 - 1.78) 0.086
Model-2 1.40 (1.31 - 1.49) 1.43 (1.33 - 1.54) 1.39 (1.28 - 1.51) 0.920
HOMA-beta
Model-1 103.02 (100.69 - 105.4) 103.13 (98.34 - 108.15) 100.17 (93.93 - 106.83) 0.465
Model-2 107.68 (101.1 - 114.69) 105.65 (98.22 - 113.64) 102.65 (94.44 - 111.58) 0.149
HbA1c %
Model-1 5.78 (5.76 - 5.81) 5.75 (5.7 - 5.79) 5.81 (5.74 - 5.87) 0.943
Model-2 5.73 (5.67 -5.79) 5.7 (5.63 - 5.77) 5.74 (5.66 - 5.82) 0.883
Adiponectin High molecular weight (μg/ml)
Model-1 1.03 (1.00 - 1.06) 1.02 (0.96 - 1.09) 0.97 (0.89 - 1.05) 0.162
Model-2 1.01 (0.93 - 1.09) 1.02 (0.92 - 1.11) 1.01 (0.91 - 1.12) 0.920
CRP (mg/L)
Model-1 1.50 (1.43 - 1.57) 1.45 (1.31 - 1.60) 1.42 (1.24 - 1.62) 0.318
Model-2 1.39 (1.23 - 1.56) 1.34 (1.17 - 1.54) 1.22 (1.04 - 1.42) 0.042
a HOMA-IR, homeostatic model assessment-insulin resistance; HOMA-beta, homeostatic model assessment-beta cell function; CRP, C-reactive protein. Numbers of
participants differ across outcomes because participants with outlier values (response values > 4 SD from mean) were excluded. Numbers were as follows: fasting
plasma glucose: 3169, 605, 300 HOMA-IR: 3193, 612, 303, HOMA-beta: 3188, 608, 299 HbA1c: 2586, 504, 263 HMW adiponectin: 3112, 602, 303 and CRP: 3091,
603, 301.
b, c For these footnotes please refer to Table 3
Rebello et al. Nutrition Journal 2011, 10:61
http://www.nutritionj.com/content/10/1/61
Page 7 of 10plasma adiponectin concentration even at relatively high
intake levels of four cups/day [19,43], but contrasts with
one randomized trial in which consumption of one L of
Oolong tea per day increased adiponectin concentra-
tions in 22 persons with coronary artery disease [44].
The inverse association between green tea and CRP is
a finding that stands in contrast to several other studies
which observed no such association [25,43,45,46].
However, these studies were all clinical trials that exam-
ined either the acute [46] or short-term (4-8 weeks)
[25,43,45] effects of green tea intake. A longer duration
may be needed for the beneficial effects of green tea on
CRP to be manifested. Interestingly, we found no asso-
ciations between black tea and glycemic parameters or
inflammatory markers. These findings were inconsistent
with those of a prospective cohort study in Singaporean
Chinese that found an inverse association between black
tea consumption and Type-2 DM risk [4]. It is possible
that black tea alters post-prandial aspects of glucose
metabolism, which were not examined in this study.
The large multi-ethnic study population and detailed
assessments of potential confounders are strengths of
this study. Because of the cross-sectional design, the
sequence of events cannot be inferred from this study.
However, we excluded people with known diseases who
may have exhibited differential recall of lifestyle expo-
sures or were on medications that may have obscured
the effects of coffee or tea on the markers of interest.
Also, measurement error in the assessment of lifestyle
exposures is unavoidable and makes the possibility of
residual confounding a concern. However, as coffee con-
sumption was associated with less health-conscious life-
style behaviors, it is less likely that un-measured
confounders would weaken the inverse association
between coffee and IR. Green tea intake was associated
with some favorable lifestyle behaviors and higher edu-
cation, and it is thus possible that green tea may have
served as a proxy for an unmeasured or imperfectly
measured beneficial exposure in this study.
Conclusions
These data suggest a beneficial effect of coffee consump-
tion on insulin sensitivity in Asians at modest levels of
consumption. This association did not appear to be
mediated by anti-inflammatory mechanisms, and other
pathways should be considered for mechanistic studies.
Additional material
Additional file 1: Additional Tables. Table S1: This table contains
information on participant characteristics across categories of tea intake.
Table S2: This table contains information on the associations between
total tea consumption and metabolic markers.
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